EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

SAFETY EVALUATION OF SIDDHA FORMULATION THEER ANDHASKHAN MATHIRAI BY ACUTE AND SUB-ACUTE TOXICITY STUDIES IN WISTAR RATS

R. Naveen Kumar*, N. Anbu and D.Sivaraman

ABSTRACT

In Siddha system of medicine, thousands of raw drugs are used to treat various kinds of diseases. These drugs are categorized into four groups namely Metals, Minerals, Herbals and Animal products. But in certain life-threatening diseases and especially in many chronic diseases, the herbal medicines alone have not been much effective. Herbal and herbo mineral preparations are being traditionally used in Indian system of Medicine especially in Siddha system. According to the Shelf life Herbo mineral preparations have more actions then any other drugs. Here THEER ANDHASKHAN MATHIRAI(TAM) is prepared as per Siddha classical text book Anuboga vaithiya Navaneetham, part 4, page no:105 – 106 to treat RA. Before clinical study there should be a need to undergone Preclinical trial as per WHO guidelines. The Clinical study was approved by Institutional Ethics Committee (IEC) and the approval number is IEC No: GSMC-CH-ME-5/004/2018. It was registered in Clinical Trials Registry-India (CTRI) and the registered number is CTRI/2019/08/020797.The present preclinical study aims to carry out safety and toxicity of the experimental protocol Theer Andhaskhan Mathirai was approved by Institutional Animal Ethics Committee (IAEC) of Sathyabama University, Chennai, Tamil Nadu, India. The approval number is SU/CLATR/IAEC/XIII/125/2019. Acute & Sub acute toxicity studies were carried out as per OECD guidelines 423 and 407. Hematological Parameters, biochemical parameters histopathological studies were performed for all animals. The study concludes that on oral administration of 100mg/kg of bodyweight of TAM to Wistar albino rats, there was no change in behaviour movements and no characteristic clinical sign of toxicity or mortality observed. From the result it was concluded that the Siddha preparation TAM offers wide margin of safety in tested rodents and further long term usage of drugs will be considered as safe for the ailment of various disease.7

Keywords: Siddha, OECD guidelines, Acute, Sub-acute, TAM, IAEC.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: APRIL ISSUE PUBLISHED

    APRIL Issue has been successfully launched on 1 April 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )